openPR Logo
Press release

Use of Peptide Therapeutics in Treatment of Diverse Medical Conditions Stimulates Market Growth

01-10-2017 03:16 PM CET | Health & Medicine

Press release from: Transparency Market Research - Biotechnology

Use of Peptide Therapeutics in Treatment of Diverse Medical

According to a new market study released by Transparency Market Research (TMR), the global peptide therapeutics market will be valued at US$23.7 bn by 2020, increasing from its 2013 valuation of US$18.9 bn. If the projected figure hold true, the market will rise at a moderate 2.8% CAGR from 2014 to 2020. The report is titled “Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020” and is available for sale on the company website.

Browse the full Peptide Therapeutics Market (by Applications, by Route of Administration, and by Marketing Status) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 report at

Therapeutic peptides have received acceptance in the treatment of several diseases such as metabolic disorders, cancer, nervous system disorders, gastrointestinal disorders, acromegaly, hematological disorders, cardiovascular disorders, infections, and respiratory disorders, among others. Due to the efficacy of peptides for the treatment of a large number of medical conditions, further research and development has resulted in a rich pipeline of novel peptides that deliver better therapeutic effects.

Though animal sources such as venom constitute the major source for peptide research, microbial sources are also being examined for their efficacy for treatment of various medical conditions. The growing variety of sources as well as applications of peptide therapeutics is boosting growth prospects of the global peptide therapeutics market. However, despite extensive research, oral administering of therapeutic peptides still remains a challenge for researchers, which is indirectly hampering the peptide therapeutics market. Unfavorable physiological conditions such as the presence of proteolytic enzymes and acidic pH pose a challenge for oral administering of peptide therapeutics. Moreover, low intestinal penetrability of peptides also adds to the low bioavailability of these substances.

Lately, a strong trend has been observed in the peptide therapeutics market: whilst new peptide therapeutic drugs receive regulatory permission, several older peptide therapeutic drugs will go off-patent during the forecast period. In addition, difficulties associated with imitating the precise effects of biologics are a major reason for generic drug manufacturers to face drug approval issues. Thus, generic peptide therapeutic drugs are priced only 70-80% as much as branded peptide therapeutics. Due to this price gap, high demand for generic versions is expected to help the peptide therapeutics market overcome its restraints.

Presently, the generic peptide therapeutic leuprolide is retailed under the brand names Eligard, Lupron, and Enantone, of which Lupron and Enantone constitute sales over US$800 mn across the world.On the competitive front, currently, Teva Pharmaceutical Industries Ltd., Novo Nordisk, and Takeda Pharmaceutical Co. Ltd. collectively account for more than 50% of the global peptide therapeutics market. However, the patent expiration of Copaxone in 2014 and Velcade in 2017 will lead to launch of their generic alternatives. Some other prominent players in the global peptide therapeutics market are AstraZeneca plc, Eli Lilly & Co., Merck & Co., Novartis International, and AbbVie Inc.

Download Sample Copy of Report at :

The global peptide therapeutics market has been segmented as below:

Global Peptide Therapeutics Market, by Application


Zoladex (goserelin)
Velcade (bortezomib)
Lupron/ Enantone/ Eligard (leuprorelin)

Angiomax (bivalirudin)
Integrilin (eptifibatide)
Central Nervous System

Copaxone (glatiramer)
Metabolic Disorders

Victoza (liraglutide)
Byetta (exenatide)

Incivek (telaprevir)
Victrelis (boceprevir)
Hematological Disorders

Firazyr (icatibant)
Kalbitor (ecallantide)
Gastrointestinal Disorders

Gattex (teduglutide)
Linzess (linaclotide)
Respiratory Disorders
Other Applications
Global Peptide Therapeutics Market, by Route of Administration

Global Peptide Therapeutics Market, by Marketing Status

Global Peptide Therapeutics Market, by Geography

North America
Asia Pacific
Rest of the World
Browse : Our new press releases

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Mr. Sudip. S

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453



This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Use of Peptide Therapeutics in Treatment of Diverse Medical Conditions Stimulates Market Growth here

News-ID: 409625 • Views: 998

More Releases from Transparency Market Research - Biotechnology

Digital Dispenser Systems Market Overview by Increasing Demand and Sales 2017 to …
A dispenser is a device that automatically dispenses a single item or a measured quantity. Digital dispenser systems are complete devices that can be used for dispensing and filling buffer solutions, culture media and other fluids with perfect accuracy and efficiency. These digital dispensers can quickly dispense volumes ranging from 0.1ml to 9999ml unlike manual pipetting, hand pouring or bottle top style dispensers. In this system, there is a digital
Europe Molecular Diagnostics Market is Expected to Register a CAGR of 6.6% From …
The market for molecular diagnostics in Europe is slated to see competition increase in the near future as companies focus on research and development to come up with better products. With product differentiations and customizations they are attempting to increase their sales and revenues. To that end they are partnering or collaborating with research institute. Dominant players are also focusing on mergers and acquisitions to increase their market share. Report Overview
Acute Care Needleless Connectors Market to Reach an Opportunity of US$ 972.0 Mn …
Conventional needle based I.V. catheters, administration sets, and syringes are used for intravenous administration of fluids. However, use of needle based IV systems give rise to needlestick injuries to healthcare workers leading increased incidences of blood borne infections. Therefore, needleless connectors were introduced in 1980s to enhance the safety of healthcare workers. As a result, rate of needlestick injuries decreased significantly in later years. However, eventually it was observed that
Commercial Aviation Crew Management System Market - Rising Air Traffic Needs Man …
Automated systems have become an integral part of the aviation industry. The operational efficiency that they bring about has increased their demand. This has bolstered the market for commercial aviation management system. These systems ensure that the industry does not suffer backlogs due to unfavorable management of the crew. Hence, they have become extremely important in the aviation industry. Obtain Brochure For Latest Technology Advancements @ The entire aviation industry is

All 5 Releases

More Releases for Therapeutic

Diarrhea Therapeutic and Disease Pipeline Review H1
Summary Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle. GET SAMPLE REPORT @ Report Highlights Pharmaceutical and Healthcare latest pipeline guide Diarrhea - Pipeline Review,
Therapeutic Socks Market
Therapeutic Socks Market Overview Compression therapy is a safe and cost-effective method of treating wounds, vein thrombosis, phlebitis and providing post-surgery care. It relies on a simple yet efficient principle – applying an elastic garment around a limb. A relatively new form of treatment, it is anticipated to post rapid growth during the next decade. Compression therapy includes garments like leggings, shirts, socks and stockings. The therapeutic socks market, otherwise known
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperio …
"The Report Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -" Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis in the product portfolios and development pipelines of ten major classes of therapeutic proteins and
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @ . Report Description: Pharmaceutical guide Colorectal Cancer - Pipeline Review H1
Global Therapeutic Drug Monitoring Market 2017-2021
MarketResearchReports.Biz presents this most up-to-date research on "Global Therapeutic Drug Monitoring Market 2017-2021" Description Therapeutic drug monitoring is a branch of clinical pharmacology and clinical chemistry that specializes in the measurement of drug concentration in blood. It is mainly performed on the drugs with a narrow therapeutic window. Therapeutic drug monitoring aims at improving patient care by regulating the dose of drugs. It is based on a priori pharmacogenetic, demographic, and clinical
2022 Global Therapeutic Drug Monitoring Market Status
Big Market Research adds a report “Global Therapeutic Drug Monitoring Market -Size, Share, Trends, Forecast, Growth, Opportunities, 2022” This New Version Therapeutic Drug Monitoring Market Research Report is a deep market research report in this market. This report focused on global and regional market, major manufacturers, as well as the segment market details on different classifications and applications. Get Sample Copy of report @ First, this report analyzed the basic scope of